STONEPINE CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | NKTR | 85K | $4.84M |
 | ANGO | 60K | $670.20K |
 | SVRA | 60K | $214.20K |
 | RZLT | 40K | $376.00K |
 | SNDX | 37K | $572.32K |
 | LRMR | 25K | $80.75K |
 | SLNO | 24K | $1.62M |
 | JSPR | 20K | $48.08K |
 | RARE | 20K | $601.60K |
 | ESTA | 11K | $433.88K |
 | ABVX | 3K | $212.25K |
Nektar Therapeutics
NKTR
Shares Held
85K
Value
$4.84M
AngioDynamics, Inc.
ANGO
Shares Held
60K
Value
$670.20K
Savara Inc.
SVRA
Shares Held
60K
Value
$214.20K
Rezolute, Inc.
RZLT
Shares Held
40K
Value
$376.00K
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
37K
Value
$572.32K
Larimar Therapeutics, Inc.
LRMR
Shares Held
25K
Value
$80.75K
Soleno Therapeutics, Inc.
SLNO
Shares Held
24K
Value
$1.62M
Jasper Therapeutics, Inc.
JSPR
Shares Held
20K
Value
$48.08K
Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
20K
Value
$601.60K
Establishment Labs Holdings Inc.
ESTA
Shares Held
11K
Value
$433.88K
Abivax S.A.
ABVX
Shares Held
3K
Value
$212.25K